Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Equities
603707
CNE100002WP3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.69 CNY | -0.15% | -0.07% | -8.73% |
05-01 | NKFPharma Gets Nod to Register New Cancer Treatment | MT |
04-27 | Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.73% | 3.06B | |
+33.43% | 700B | |
+27.76% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+16.06% | 236B | |
+6.74% | 202B | |
-9.45% | 197B | |
+4.26% | 161B |
- Stock Market
- Equities
- 603707 Stock
- News Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
- NKFPharma Unit Gets US FDA Nod for Cancer Drug